AH Allscripts Healthcare Solutions, INC. Stock: price and management transactions · United States · SEC (Form 4)Follow the Allscripts Healthcare Solutions, INC. share price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, Allscripts Healthcare Solutions, INC. has recorded 61 public disclosures. Market capitalisation: €516.6m. The latest transaction was reported on 12 December 2022 (Cession). Among the most active insiders: Black Paul. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,925 of 29,064 companies
FCF yld 16%
Earn yld -17%
EV/EBITDA 12.6x
ROE -31%
Gross mgn 52%
Net mgn -15%
Debt/EBITDA 3.8x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 December 2022
All Executives61 Thresholds0 Prospectus0 Other0
Declarations 61 total
▼ SVP General Counsel · Executives · 12 Dec 2022
8,642 shares @ US$18.4209 17.4% of flow Common Stock SEC:0001209191-22-060702:0
▼ Director · Executives · 6 Dec 2022
43,134 shares @ US$18.4733 50.5% of flow Common Stock SEC:0001209191-22-060156:0
▼ CEO · Executives · 15 Nov 2022
10,000 shares @ US$18.1388 4.3% of flow Common Stock SEC:0001209191-22-057358:0
▼ SVP General Counsel · Executives · 10 Nov 2022
19,793 shares @ US$18.15 41.3% of flow Common Stock SEC:0001209191-22-056630:0
▼ Chief Financial Officer · Executives · 13 Sept 2022
7,000 shares @ US$16.6187 99.6% of flow Common Stock SEC:0001209191-22-049927:0
● SVP General Counsel · Executives · 3 Sept 2022
1,223 shares @ US$16.63 2.4% of flow Common Stock SEC:0001209191-22-048767:0
▼ Chief Financial Officer · Executives · 15 Aug 2022
24 shares @ US$17.65 0.4% of flow Common Stock SEC:0001209191-22-046729:0
▼ CEO · Executives · 15 Aug 2022
10,000 shares @ US$17.457 4.2% of flow Common Stock SEC:0001209191-22-046010:0
▼ CEO · Executives · 16 Aug 2022
10,000 shares @ US$17.4375 4.2% of flow Common Stock SEC:0001209191-22-046010:1
◆ Director · Executives · 27 Jun 2022
12,756 shares 0Common Stock SEC:0001209191-22-039635:0
◆ Director · Executives · 27 Jun 2022
12,756 shares 0Common Stock SEC:0001209191-22-039633:0
◆ Director · Executives · 27 Jun 2022
12,756 shares 0Common Stock SEC:0001209191-22-039634:0
◆ Director · Executives · 27 Jun 2022
12,756 shares 0Common Stock SEC:0001209191-22-039630:0
◆ Director · Executives · 27 Jun 2022
12,756 shares 0Common Stock SEC:0001209191-22-039632:0
▼ Director · Executives · 10 Jun 2022
60,000 shares @ US$16.5816 0.18% mcap 6.9% of flow Common Stock SEC:0001209191-22-036324:0
▼ Director · Executives · 6 Jun 2022
65,450 shares @ US$17.305 0.21% mcap 7.7% of flow Common Stock SEC:0001209191-22-034883:0
▼ Director · Executives · 7 Jun 2022
75,000 shares @ US$17.3501 8.2% of flow Common Stock SEC:0001209191-22-034883:1
▼ Director · Executives · 3 Jun 2022
75,000 shares @ US$17.3334 0.23% mcap 8.8% of flow Common Stock SEC:0001209191-22-034529:0
▼ Director · Executives · 27 May 2022
47,347 shares @ US$16.8525 0.14% mcap 100.0% of flow Common Stock SEC:0001209191-22-032832:0
▼ Director · Executives · 27 May 2022
6,028 shares @ US$16.7519 0.018% mcap 21.7% of flow Common Stock SEC:0001209191-22-032834:0
● SVP & Chief HR Officer · Executives · 25 May 2022
1,552 shares @ US$17.30 0.0049% mcap 100.0% of flow Common Stock SEC:0001209191-22-032292:0
▼ Director · Executives · 17 May 2022
50,000 shares @ US$18.1792 0.17% mcap 6.3% of flow Common Stock SEC:0001209191-22-030672:0
▼ CEO · Executives · 16 May 2022
10,000 shares @ US$17.9421 0.033% mcap 4.9% of flow Common Stock SEC:0001209191-22-029684:0
▼ Director · Executives · 13 May 2022
50,000 shares @ US$18.0138 0.17% mcap 6.3% of flow Common Stock SEC:0001209191-22-029151:0
◆ SVP General Counsel · Executives · 10 May 2022
32,450 shares 0Common Stock SEC:0001209191-22-028312:0
25 of 61 declarations
Load more (36 remaining) 关于 Allscripts Healthcare Solutions, INC. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.(股票代码 MDRX)是一家总部位于美国的医疗保健技术公司,在美国纳斯达克上市。该公司以其前身名称 Allscripts 而闻名;自 2023 年 1 月 1 日起,公司正式更名为 Veradigm Inc.,但 MDRX 股票代码仍在使用。公司总部位于伊利诺伊州芝加哥,长期以来一直是美国医疗保健 IT 领域知名的参与者之一。该公司成立于 2000 年,通过有机发展和收购,逐渐发展成为一个服务于医疗服务提供者和其他医疗保健利益相关者的软件和数据平台。
其核心业务围绕医疗保健信息技术解决方案,包括电子健康记录(EHRs)、实践管理、患者参与、数据连接、分析以及与收入周期相关的服务。历史上,该公司服务于医生、医疗团体、医院、卫生系统、支付方和生命科学公司。经过投资组合简化和资产剥离后,业务更加专注于连接、医疗保健数据和基于网络的解决方案,战略重点是可互操作的平台和可操作的数据,而不仅仅是独立的临床软件。
从竞争角度来看,MDRX 在一个高度分散但竞争激烈的市场中运营,该市场由少数大型 EHR 供应商和众多患者参与、收入周期管理、互操作性和分析领域的专业公司主导。其定位依赖于软件、网络覆盖和数据能力的结合。该公司强调 Veradigm Network,这是一个由解决方案和合作伙伴组成的社区,旨在连接医疗服务提供者、支付方和生命科学组织,并将真实世界的医疗保健数据转化为决策支持和商业洞察。
主要产品和服务包括 EHR 平台、医生诊室解决方案、患者沟通工具、集成和分析功能,以及为医疗服务提供者、支付方和生命科学市场量身定制的产品。从地理上看,该业务主要集中在美国,尽管该公司历史上曾有选择性的国际合作关系,并且根据当时的收购和业务线,拥有更广泛的技术足迹。
最近的里程碑主要是战略重组。2022 年,公司完成了将其医院和大型医生诊所业务出售给 Constellation Software 的交易,这是一项重大的投资组合重塑举措。2023 年,公司更名为 Veradigm 正式标志着 Allscripts 身份的终结,以及更数据驱动的品牌战略的开始。最近,公司继续强调其数据网络、连接能力和医疗保健分析定位,同时在一个受监管复杂性、行业整合、网络安全风险以及持续改善账单、索赔和护理协调工作流程压力的环境中运营。